OMICS International https://www.omicsonline.org/ OMICS International is a scientific organization that drives the progress of research through open access journals and organizes international conferences, The best in science news, commentary, and research. https://www.omicsonline.org/ArchiveJCST/currentissue-cancer-science-therapy-open-access.php Journal of Cancer Science & Therapy Volume 9, Issue 8 https://www.omicsonline.org/open-access/current-management-approaches-of-chronic-myeloid-leukemia-1948-5956-1000480.php?aid=92912 Current Management Approaches of Chronic Myeloid Leukemia Atalay Mulu Fentie, Minyahi Alebachew Woldu, Belete Ayalneh Worku https://www.omicsonline.org/open-access/circulating-tumor-cells-ctcs-as-biomarker-for-pd1pdl1-blockadeimmunotherapy-1948-5956-1000479.php?aid=92567 Circulating Tumor Cells CTCs as Biomarker for PD1PDL1 BlockadeImmunotherapy Chunyan YUE and Zhiyuan HU https://www.omicsonline.org/open-access/breast-cancer-arising-from-a-suspected-fibroadenoma-during-pregnancya-case-report-and-review-of-literature-1948-5956-1000478.php?aid=92566 Breast Cancer Arising from a Suspected Fibroadenoma during PregnancyA Case Report and Review of Literature Yasamin Ghazvini Kor, Mehdi Saeedan and Mohamed Sobhy Badr Sobei https://www.omicsonline.org/open-access/integrative-analysis-of-transcriptome-and-micrornome-profiles-incholangiocarcinoma-1948-5956-1000477.php?aid=92564 Integrative Analysis of Transcriptome and MicroRNome Profiles inCholangiocarcinoma Faacutebio E Severino, Claudia N Hasimoto, Maria A M Rodrigues, Juan C Llanos and Patricia P Reis https://www.omicsonline.org/open-access/is-it-possible-to-reduce-the-risk-of-hepatocellular-carcinoma-by-takingstatin-in-diabeties-mellitus-patients-with-hbv-or-hcv-1948-5956-1000574.php?aid=92563 Is It Possible To Reduce the Risk of Hepatocellular Carcinoma by TakingStatin in Diabeties Mellitus Patients with HBV or HCV GueiFen Chiu, YuHan Chang, DenChang Wu, MingTsang Wu4 and KunDer Lin https://www.omicsonline.org/open-access/clinical-significance-and-therapeutic-potential-of-the-programmed-deathligand1-pdl1-and-pdl2-expression-in-human-colorectal-cancer-1948-5956-1000475.php?aid=92528 Clinical Significance and Therapeutic Potential of the Programmed DeathLigand1 PDL1 and PDL2 Expression in Human Colorectal Cancer Martin Gasser, Matthias Koenigshausen, Martin R Grimm, Claudia Stein, Tanja Grimmig, Martin Wagner, Melissa Yeung, Roberta Rehder, Ekaterina Nichiporuk Stumpf, Roman Moench, Carmen M Ribas, Sudipta Tripathi, Anil Chandraker, Uwe Maeder, Uwe Heemann, ChristophThomas Germer and Ana Maria WaagaGasser